Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TREASURE trial of valsartan versus usual care in women with asymptomatic subclinical heart failure
NL-OMON58950Phase 4Recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of valsartan in heart failure (HF) and diastolic dysfunction (2 arms), sponsored by Maastricht University Medical Center+. Primary endpoints: Left ventricular hypertrophy, Concentric remodeling and 3 more. Started Mar 2024; status: recruiting.
02
Drugs
valsartan
03
Conditions
heart failure (HF)diastolic dysfunction
Beyond the preview
Go deeper on NL-OMON58950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58950.